1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $25 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.
Join Mergr to view the latest updates and news from 1315 Capital.
In the last 3 years, 1315 Capital has acquired 2 companies. It has also invested in 4 others.
1315 Capital’s most common sectors for investment are life science (43%) and medical products (43%). The Firm’s most common investment types include venture (58%) and divestiture (29%). In total, 1315 Capital has invested in 6 US states.
Join Mergr to view 1315 Capital’s full profile and discover more small private equity firms just like it.
No obligation. Cancel anytime.